Hot Features
Premium
Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Período:
Tipo de Línea:
| Volume | 25 |
|
|||||
| Noticias | - | ||||||
| Máximo del Dia | Mínimo Máximo |
||||||
| Minimo del Dia | |||||||
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| ADC Therapeutics SA | ADCT | NYSE | Acción Común |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 3.73 | 04:28:09 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 3.73 |
| Operaciones | Volume Operado de la Acción | Volumen promedio | Rango 52 semanas |
|---|---|---|---|
| 1 | 25 | - | 0.359908 - 6.04 |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| 04:30:03 | 25 | US$ 3.73 | USD |
Información Financiera ADC Therapeutics SA ADCT
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 307.84M | 82.53M | - | 69.56M | -234.53M | -2.84 | - |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre ADC Therapeutics SA ADCT
| Fecha | Hora | Fuente | Noticias Artículo |
|---|---|---|---|
| 15/5/2024 | 06:15 | GlobeNewswire Inc. | ADC Therapeutics to Participate in the H.C. Wainwright 2nd.. |
| 14/5/2024 | 11:32 | Edgar (US Regulatory) | Form 8-K - Current report |
| 09/5/2024 | 15:06 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 09/5/2024 | 06:15 | GlobeNewswire Inc. | ADC Therapeutics to Participate in 2024 RBC Capital Markets.. |
| 08/5/2024 | 15:07 | Edgar (US Regulatory) | Form 8-K - Current report |
| 07/5/2024 | 15:06 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities |
| 07/5/2024 | 15:02 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 06/5/2024 | 06:30 | GlobeNewswire Inc. | ADC Therapeutics Announces $105 Million Underwritten.. |
| 06/5/2024 | 05:51 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 06/5/2024 | 05:38 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 06/5/2024 | 05:29 | Edgar (US Regulatory) | Form 8-K - Current report |
| 06/5/2024 | 05:10 | GlobeNewswire Inc. | ADC Therapeutics Reports First Quarter 2024 Financial.. |
Histórico de Datos ADCT
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.12 | 4.32 | 3.67 | 3.97 | 543,634 | -0.39 | -9.47% |
| 1 Month | 4.99 | 5.17 | 3.67 | 4.36 | 610,204 | -1.26 | -25.25% |
| 3 Months | 5.05 | 5.38 | 3.23 | 4.50 | 565,217 | -1.32 | -26.14% |
| 6 Months | 0.7431 | 6.04 | 0.6883 | 3.29 | 753,741 | 2.99 | 401.95% |
| 1 Year | 2.58 | 6.04 | 0.359908 | 2.64 | 566,216 | 1.15 | 44.57% |
| 3 Years | 20.58 | 32.00 | 0.359908 | 6.15 | 431,251 | -16.85 | -81.88% |
| 5 Years | 30.00 | 56.5899 | 0.359908 | 10.62 | 388,411 | -26.27 | -87.57% |
